Vaccinia virus-induced inhibition of nitric oxide production

Journal of Surgical Research

Volumn 111, Issue 1, 2003, Pages 127-135

  Bellows, Charles F ^a   Garry, Robert F ^a   Jaffe, Bernard M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Macrophages; Nitric oxide; Vaccinia virus

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; NITRIC OXIDE; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXPOSURE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SPECIES COMPARISON; ULTRAVIOLET IRRADIATION; VACCINIA VIRUS; VIRUS INACTIVATION; VIRUS INHIBITION; VIRUS PARTICLE;

EID: 0038385342     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00079-9     Document Type: Article

References (40)

1. Mannick J.B. The antiviral role of nitric oxide. Res. Immunol. 146:1995;693.
2. 2. J. Leukoc. Biol. 61:1997;712.
3. Harris N., Buller R.M., Karupiah G. Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69:1995;910.
4. Karupiah G., Xie Q., Buller R.M., Nathan C., Duarte C., MacMicking J.D. Inhibition of viral replication by interferon-γ induced nitric oxide synthase. Science. 261:1993;1445.
5. Croen K.D. Evidence for an antiviral effect of nitric oxide Inhibition of herpes simplex virus type 1 replication . J. Clin. Invest. 91:1993;2446.
6. Melkova Z., Esteban M. Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase. J. Immunol. 155:1995;5711.
7. Bi Z., Reiss C.S. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:1995;2208.
8. Sanders S.P., Siekierski E.S., Porter J.D., Richards S.M., Proud D. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J. Virol. 72:1998;934.
9. Persichini T., Colasanti M., Fraziano M., Colizzi V., Ascenzi P., Lauro G.M. Nitric oxide inhibits HIV-1 replication in human astrocytoma cells. Biochem. Biophys. Res. Commun. 254:1999;200.
10. Rolph M.S., Ramshaw I.A., Rockett K.A., Ruby J., Cowden W.B. Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance. Virology. 217:1996;470.
11. Van den Broek M., Bachmann M.F., Kohler G., Barner M., Escher R., Zinkernagel R., Kopf M. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with as limited role of IFN-γ and nitric oxide synthetase 2. J. Immunol. 164:2000;371.
12. Wolkow P.P. Involvement and dual effects of nitric oxide in septic shock. Inflamm. Res. 47:1998;152.
13. Albina J.E., Abate J.A., Henry W.L. Jr. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-simulated T cell proliferation Role of IFN-γ in the induction of nitric oxide-synthesizing pathway . J. Immunol. 147:1991;144.
14. Prabhakar S.S., Zeballos G.A., Montoya-Zavala M., Leonard C. Urea inhibits inducible nitric oxide synthase in macrophage cell line. Am. J. Physiol. 273:1997;C1882.
15. Heck D.E., Laskin D.L., Gardner C.R., Laskin J.D. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes Potential role for nitric oxide in the regulation of wound healing . J. Biol. Chem. 267:1992;21277.
16. BB in vascular smooth muscle cells. Eur. J. Pharmacol. 216:1992;379.
17. 2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. Circ. Res. 82:1998;204.
18. Bogan C., Vodovotz Y., Paik J., Xie Q.W., Nathan C. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leukoc. Biol. 55:1994;227.
19. McCall T.B., Palmer R.J., Moncada S. Interleukin-8 inhibits the induction of nitric oxide synthase in rat peritoneal neutrophils. Biochem. Biophys. Res. Commun. 186:1992;680.
20. Cunha F.Q., Moncada S., Liew F.Y. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem. Biophys. Res. Commun. 182:1992;1155.
21. Smith G.L., Symons J.A., Khanna A., Vanderplasschen A., Alcami A. Vaccinia virus immune evasion. Immunol. Rev. 159:1997;137.
22. Ribeiro R.A., Freitas H.C., Campos M.C., Santos C.C., Figueiredo F.C., Brito G.C., Cunha F.Q. Tumor necrosis factor-α and interleukin-1β mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. J. Urol. 167:2002;2229.
23. Lyon J.A., Hinshaw V.S. Inhibition of nitric oxide induction from avian macrophage cell lines by influenza virus. Avian Dis. 37:1993;868.
24. Adler H., Frech B., Meier P., Jungi T.W., Peterhans E. Noncytopathic strains of bovine viral diarrhea virus prime bovine bone marrow-derived macrophages for enhanced generation of nitric oxide. Biochem. Biophys. Res. Commun. 202:1994;1562.
25. Dunlap R.C., Patt J.K. Reactivation of heated vaccinia virus by UV-irradiated vaccinia virus. Proc. Soc. Exp. Biol. Med. 136:1971;1.
26. Brossart W., Nuss D.L., Paoletti E. Effect of UV irradiation on the expression of vaccinia virus gene products synthesized in a cell-free system coupling transcription and translation. J. Virol. 26:1978;673.
27. Bellows C.F., Jaffe B.M. Glutamine is essential for nitric oxide synthesis by murine macrophages. J. Surg. Res. 86:1999;213.
28. Baskin H., Ellerman-Eriksen S., Lovmand J., Mogensen S.C. Herpes simplex virus type 2 synergizes with interferon-γ in the induction of nitric oxide production in mouse macrophages through autocrine secretion of tumor necrosis factor-α J. Gen. Virol. 78:1997;195.
29. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141:1988;2407.
30. Karupiah G., Fredrickson T.N., Holmes K.L., Khairallah L.H., Buller R.M. Importance of interferons in recovery from mousepox. J. Virol. 67:1993;4214.
31. Conti C., Mastromarino P., Tomao P., DeMarco A., Pica F., Santoro M.G. Inhibition of poliovirus replication by prostaglandins A and J in human cells. Antimicrob. Agents Chemother. 40:1996;367.
32. 1. Proc. Soc. Exp. Biol. Med. 170:1982;25.
33. Sakuma I., Stuehr D.J., Gross S.S., Nathan C., Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA. 85:1988;8664.
34. Granger D.L., Hibbs J.B. Jr, Perfect J.R., Durack D.T. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J. Clin. Invest. 85:1990;264.
35. Kwon S., George S.C. Synergistic cytokine-induced nitric oxide production in human alveolar epithelial cells. Nitric Oxide: Biol. Chem. 3:1999;349.
36. Ray C.A., Black R.A., Kronheim S.R., Greenstreet T.A., Sleath P.R., Salvesen G.S., Pickup D.J. Viral inhibition of inflammation cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme . Cell. 69:1992;597.
37. Kettle S., Alcami A., Khanna A., Ehret R., Jassoy C., Smith G.L. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1β-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1 β-induced fever. J. Gen. Virol. 78:1997;677.
38. Spriggs M.K., Hruby D.E., Maliszewski C.R., Pickup D.J., Sims J.E., Buller R.M., VanSlyke J. Vaccinia and cowpox viruses encodes a novel secreted interleukin-1-binding protein. Cell. 71:1992;145.
39. Alcami A., Smith G.L. A soluble receptor for interleukin-1β encoded by vaccinia virus a novel mechanism of virus modulation of the host response to infection . Cell. 71:1992;153.
40. Biron C.A. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr. Opin. Immunol. 6:1994;530.